# Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

> **NCT00518453** · PHASE2 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 129 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Surface antigen inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT00518453
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2016-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518453, "Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00518453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*